Australia markets closed

Aerovate Therapeutics, Inc. (AVTE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.6600-0.0100 (-0.60%)
At close: 04:00PM EDT
1.6599 -0.00 (-0.01%)
After hours: 07:54PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-82,187
-75,521
-51,511
-22,963
-9,611
Depreciation & amortisation
103
96
68
15
1
Stock-based compensation
13,722
11,906
5,476
2,043
58
Change in working capital
2,480
9,798
7,755
-6,510
974
Accounts payable
-1,450
-164
1,368
609
37
Other working capital
-69,153
-56,920
-39,317
-27,580
-7,859
Other non-cash items
-
-
-
-
719
Net cash provided by operating activities
-69,027
-56,778
-39,122
-27,399
-7,859
Cash flows from investing activities
Investments in property, plant and equipment
-
-142
-195
-181
-
Purchases of investments
-123,123
-123,982
-147,623
-113,253
0
Sales/maturities of investments
128,583
136,000
154,744
0
-
Net cash used for investing activities
5,334
11,876
6,926
-113,434
0
Cash flows from financing activities
Common stock issued
-
44,888
0
126,945
0
Other financing activities
-
-234
-371
-
-
Net cash used provided by (used for) financing activities
46,244
45,996
396
190,457
8,918
Net change in cash
-17,449
1,094
-31,800
49,624
1,059
Cash at beginning of period
26,571
22,397
54,197
4,573
3,514
Cash at end of period
9,122
23,491
22,397
54,197
4,573
Free cash flow
Operating cash flow
-69,027
-56,778
-39,122
-27,399
-7,859
Capital expenditure
-
-142
-195
-181
-
Free cash flow
-69,153
-56,920
-39,317
-27,580
-7,859